33 studies found for:    " August 08, 2012":" September 07, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Terminated ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART
Conditions: HIV;   Atherosclerosis
Interventions: Drug: niacin/laropiprant;   Drug: Placebo
22 Recruiting The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception
Conditions: Pregnancy;   HIV;   AIDS
Intervention: Drug: Norethindrone acetate
23 Recruiting Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up
Conditions: Coronary Heart Disease;   Heart Failure;   HIV;   AIDS;   Metabolic Syndrome
Intervention: Other: Comprehensive non invasive cardiovascular examination
24 Recruiting HIV Reverse Cholesterol Transport Study
Conditions: HIV;   Dyslipidemia
Intervention:
25 Active, not recruiting Rapid Initiation of Antiretroviral Therapy to Promote Early HIV/AIDS Treatment in South Africa (RapIT Study)
Condition: HIV
Intervention: Other: Rapid ART initiation
26 Recruiting Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel
Condition: HIV
Interventions: Drug: Oral FTC/TDF (Daily Emtricitabine/Tenofovir Disoproxil fumarate Tablet);   Drug: Rectal Daily TFV RG 1% gel (Rectally applied Tenofovir Reduced Glycerin 1% Gel);   Drug: Rectal RAI-associated TFV RG 1% gel (Receptive Anal Intercourse Associated rectally applied Tenofovir Reduced Glycerin 1% Gel)
27 Active, not recruiting ALternative TEnofovir Dosing in Adults With Moderate Renal Function Impairment
Condition: HIV
Intervention: Other: Tenofovir Dose Adjustment
28 Recruiting A Study to Assess Cerebrospinal Fluid INflammatory Markers After Addition of Maraviroc to MONotherapy Darunavir/Ritonavir - The CINAMMON Study
Condition: HIV
Intervention: Drug: maraviroc
29 Completed Preliminary Evaluation of a Point-Of-Care Liver Function Test
Conditions: HIV;   Tuberculosis;   Drug-Induced Liver Injury
Intervention: Device: Diagnostics for All liver function test (LFT)
30 Not yet recruiting Efficacy and Safety of Tenofovir Plus Lamivudine Plus Efavirenz Regimen as First-line Antiretroviral Therapy
Condition: AIDS/HIV PROBLEM
Intervention: Drug: TDF+3TC+EFV
31 Not yet recruiting Raltegravir-based Antiretroviral Therapy for Resistant HIV-1 Infection
Condition: AIDS/HIV PROBLEM
Interventions: Drug: RAL+TDF+LPV/r;   Drug: 3TC+TDF+LPV/r
32 Recruiting A Study of Selumetinib in Patients With Kaposi's Sarcoma
Condition: AIDS-related Kaposi's Sarcoma
Intervention: Drug: Selumetinib
33 Completed Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342
Condition: Tuberculosis
Intervention: Biological: GSK Biologicals' investigational TB vaccine GSK 692342

Show previous page of results Previous Page (1-20) Studies Shown (21-33) Next Page
Indicates status has not been verified in more than two years